Journal
PROTEIN SCIENCE
Volume 25, Issue 5, Pages 1021-1029Publisher
WILEY
DOI: 10.1002/pro.2912
Keywords
histone methyltransferase; NSD family; cancer; structure-based drug design; molecular dynamics
Categories
Funding
- National Institutes of Health [R01GM065372]
- National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000433]
- IBM
- National Science Foundation grant (University of Michigan Chemistry REU program) [CHE-1062654]
Ask authors/readers for more resources
NSD1 is a SET-domain histone methyltransferase that methylates lysine 36 of histone 3. In the crystal structure of NSD1, the post-SET loop is in an autoinhibitory position that blocks binding of the histone peptide as well as the entrance to the lysine-binding channel. The conformational dynamics preceding histone binding and the mechanism by which the post-SET loop moves to accommodate the target lysine is currently unknown, although potential models have been proposed. Using molecular dynamics simulations, we have identified potential conformations of the post-SET loop differing from those of previous studies, as well as proposed a model of peptide-bound NSD1. Our simulations illustrate the dynamic behavior of the post-SET loop and the presence of a few distinct conformations. In every case, the post-SET loop remains in an autoinhibitory position blocking the peptide-binding cleft, suggesting that another interaction is required to optimally position NSD1 in an active conformation. This finding provides initial evidence for a mechanism by which NSD1 preferentially binds nucleosomal substrates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available